Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

101.23
Delayed Data
As of 3:59pm ET
 +0.86 / +0.86%
Today’s Change
64.03
Today|||52-Week Range
110.68
+12.13%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close100.37
Today’s open99.57
Day’s range99.01 - 101.45
Volume1,046,922
Average volume (3 months)628,458
Market cap$4.3B
Dividend yield--
Data as of 3:59pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+32.81%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+43.09%
P/E ratio119.1
Price/Sales12.92
Price/Book11.59

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-1.26-1.73%
NUVANuVasive Inc-0.14-0.24%
IARTIntegra LifeSciences...-0.25-0.33%
MASIMasimo Corp-0.79-1.55%
Data as of 4:02pm ET, 06/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.23
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Partner Offers

Search for Jobs